PhD Theses

2024

L. Verhoef (2024, May 30)

Host-cell DNA methylation biomarkers in cervical cancer screening, towards all molecular screening on self-collected samples


B.M.M. Wever (2024, January 18)

Toward a new era of cancer detection: patient-friendly solutions

Promotors: prof.dr. RDM Steenbergen; dr. M.C.G. Bleeker; Co-promotors; dr. N.E. van Trommel


S. Bach (2024, January 26)

Humoral cancer detection: Towards improved diagnostics of malignancies using bodily fluids

Promotors: prof.dr. G. Kazemier; prof.dr. RDM Steenbergen; Co-promotors; dr. I. Bahce


2023

S. Dick(2023, December 7)

Methylation markers for risk-stratification in cervical cancer screening and management of cin

Promotors: prof.dr. RDM Steenbergen; prof.dr. J.Berkhof; dr. DAM Heideman; Co-promotors; dr. MCG Bleeker


2022

R. van der Zee(2022, November 17)

Anal intraepithelial neoplasia in HIV+ men: Epidemiology, cancer risk stratification and prevention of recurrences

Promotors: prof.dr. JM Prins, prof.dr. RDM Steenbergen; Co-promotors: prof. dr. HJC de Vries, dr. O Richel

 

F. Vink (2022, October 5)

Methylation markers for cervical cancer prevention

Promotors: prof. RDM Steenbergen, prof.dr. GG Kenter; Co-promotors: dr. MCG Bleeker, Dr. DAM Heideman


R. van den Helder(2022, May 20)

Molecular biomarkers for gynecological cancer detection in cervicovaginal samples and urine

Promotors: prof.dr. RDM Steenbergen; Co-promotors: dr. M.C.G. Bleeker, dr. N.E. van Trommel

 

A.E. Hentschel (2022, March 31)

Bladder cancer: Optimizing detection and grading

Promotors: prof.dr. RDM Steenbergen, prof. R.J.A. van Moorselaar; Co-promotors: dr. Jacobus Adrianus Nieuwenhuijzen, dr. B.W.G. van Rhijn

 

2020

I. Babion (2020, June 9)

MicroRNAs in HPV-induced cervical cancer: Triage markers for cervical screening and drivers of carcinogenesis

Promotors: prof.dr. RDM Steenbergen, prof.dr. CJLM Meijer, Prof.dr. PJF Snijders †; Co-promotor: Wilting, S.M.

 

W.W. Kremer (2020, October 23)

Methylation markers for detection and management of women with cervical neoplasia

Promotors: Prof.dr. GG Kenter, Prof.dr. CJLM Meijer, Prof.dr. PJF Snijders †; Co-promotor: Prof.dr. J Berkhof



2019

Snoek, B.  (2019, November 22)

Early detection of cervical cancer: The quest for novel epigenetic biomarkers

Promotors: Dr. RDM Steenbergen, Prof.dr. CJLM Meijer, Prof.dr. PJF Snijders; Co-promotor: Dr. DAM Heideman.

 

 

van der Weele., P.S. J. (2019, October 31)

Molecular characterization of HPV infection: Evaluation of vaccine effects, viral diversity and variant development

Promotors: prof.dr. C.J.L.M. Meijer, copromotor dr. A. King

 

 

Polman, N.J. (2019, May 9)

HPV-based cervical screening: challenges and future perspectives

Promotors: prof.dr. C.J.L.M. Meijer, prof.dr. J. Berkhof, prof.dr. P.J.F. Snijders †, copromotor prof. dr. G.G. Kenter

 

2018

Verlaat, W. (2018, December 21) 

Molecular alterations during cervical carcinogenesis: Identification of novel biomarkers for triage in HPV-based cervical screening.
Promotors: Dr. RDM Steenbergen, Prof.dr. CJLM Meijer, Prof.dr. PJF Snijders; Co-promotor: Dr. DAM Heideman.

 

van Zummeren, M. (2018, November 9)

Cervical cancer prevention based on biomarkers

Promotors: Prof.dr. CJLM Meijer, Prof.dr. PJF Snijders, Prof.dr. GG Kenter

 

Hooi, D.J. (2018, October 25)

HPV and cervical cancer on Curaçao

Promotors: prof.dr. C.J.L.M. Meijer, prof.dr. G.G. Kenter
Copromotors: dr. B.I. Lissenberg-Witte dr. W.G.V. Quint

 

Miok, V. (2018, September 10) 

Comprehensive molecular characterization of HPV-induced transformation by longitudinal statistical modelling.

Promotors: Prof.dr. M. van de Wiel, dr. R.D.M. Steenbergen; Co-promotors: Dr.S.M. Wilting, Dr. W. van Wieringen

 

Donken R. (2018, March 26) 

Monitoring the HPV vaccination program in The Netherlands: Effects, changing schedule and future perspective.

Promotor: Prof.dr. CJLM Meijer; Co-promotor: dr. H.E. De Melker

 

2017

Luttmer, R.  (2017, December 20)

Genital HPV infections in women and men: improving management strategies VU University Amsterdam

Promotors: prof.dr. C.J.L.M. Meijer, prof.dr. P.J.F. Snijders, prof.dr. G.G. Kenter
co-promotor:dr. D.A.M. Heideman

 

Uijterwaal, M. (2017, January 9) 

Novel biomarkers for cervical screening and surveillance of women treated for cervical precancer. VU Univeristy Amsterdam

Promotors: Meijer, C.J.L.M.,Helmerhorst, Th.J.M.
Co-promotors: Steenbergen, R.D.M., Berkhof, J.

 

2016

Schütze, D.M. (2016, May 19).

The Road to HPV-Induced Keratinocyte Eternity: Molecular Characterization of HPV-Type Dependent In Vitro Immortalization. VU University Amsterdam.

Promotors: prof. dr. P.J.F. Snijders, prof. dr. C.J.L.M. Meijer, copromotors: dr. R.D.M. Steenbergen, dr. W.G.V.Quint

 

De Strooper, L.M.A. (2016; February 5).

Methylation analysis for the management of HPV-positive women. VU University Amsterdam.

Promotors: prof. dr. P.J.F. Snijders, prof. dr. C.J.L.M. Meijer, copromotors: dr. D.A.M. Heideman & dr. R.D.M. Steenbergen. 

 

2014
 Verhoef, V.M.J. (2014, December 10).

Improving cervical cancer screening by HPV self-sampling. VU University Amsterdam.

Promotors: prof. dr. C.J.L.M. Meijer, prof. dr. P.J.F. Snijders, copromotors: dr. F.J. van Kemenade & dr. L. Rozendaal.

 

van Baars, R. (2014, October 1)

Improving cervical cancer prevention by HPV self-sampling, colposcopy and biomarkers. Erasmus University Rotterdam.

Promotors: prof.dr. ThM Helmerhorst, prof.dr. PJF Snijders; copromotors: dr. WGV Quint, dr. WA ter Harmsel.

 

Snellenberg, S. (2014, July 01).

Uncovering epigenetic alterations of tumour suppressor and viral genes during HPV-induced cervical carcinogenesis. VU University Amsterdam.

Promotors: prof. dr. P.J.F. Snijders, prof. dr. C.J.L.M. Meijer, copromotors: dr. R.D.M. Steenbergen & prof. dr. ir. W.M.R. van Criekinge.

 

Dijkstra, M.G. (2014, May 19).

Towards a more objective way of cervical cancer screening: cervical cancer screening 2.0. VU University Amsterdam.

Promotors: prof. dr. C.J.L.M. Meijer, prof. dr. P.J.F. Snijders; copromotors: dr. W.M. van Baal & dr. F.J. van Kemenade.

 

Rietbergen, M.M. (2014, May 7)

The role of human papillomavirus in head and neck cancer. VU University Amsterdam.

Promotors: prof.dr. R Brakenhoff, prof.dr. C.R. Leemans, prof.dr. PJF Snijders, Copromotor: prof.dr. E Bloemena

 

Mollers, M. (2014, April 22).

Monitoring the impact of HPV vaccination: pre- and early post-vaccination data. VU University Amsterdam.

Promotor: prof. dr. C.J.L.M. Meijer; copromotor: H.E. de Melker

 

2013

Scherpenisse, M. (2013, October 17)

The humoral immune responses after HPV infection and prophylactic vaccination: importance of serology. VU University Amsterdam.

Promotor: CJLM Meijer; copromotors: FRM van der Klis, GAM Berbers.

 

Cornet, I. (2013, March 14)

Studies on mucosal and cutaneous HPV types: the role of genotypes and natural variants in determining their potential oncogenicity. VU University Amsterdam.

Promotor: P.J.F. Snijders. copromotor: M. Tommasino.

 

Rijkaart, D.C. (2013, March 1).

Impact of HPV testing on cervical cancer screening. VU University Amsterdam.

Promotors: CJLM Meijer, PJF Snijders; copromotors: J. Berkhof, DAM Heideman

 

Bierkens M. (2013, January 22).

Understanding the heterogeneity of high-grade CIN lesions: chromosomal and epigenetic analysis.

Promotors: Prof.dr. PJF Snijders, Prof.dr. CJLM Meijer; copromotor: dr. R.D.M. Steenbergen